Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis

被引:2
|
作者
Ghosh, Indranil [1 ]
Sangha, Sukhwinder [2 ]
Pandey, Gaurav [3 ]
Srivastava, Atul [4 ]
机构
[1] Army Hosp R&R, Dept Med, New Delhi, India
[2] Command Hosp WC, Dept Med & Nephrol, Panchkula, Haryana, India
[3] SNM Hosp, ITBP, Leh, Ladakh, India
[4] Command Hosp SC, Dept Nephrol Med & Nephrol, Pune, India
关键词
Intensive care unit; Mortality; Polymyxin B; Sepsis; Sequential organ failure assessment; SEPTIC SHOCK; HYPERGLYCEMIA; THERAPY;
D O I
10.5005/jp-journals-10071-24805
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To study the efficacy of polymyxin B hemoperfusion in addition to standard care for sepsis treatment. Materials and methods: Fifty sepsis patients (mean age 54.26 +/- 14.64 years; 68% males) were randomized to either the case group (n n = 25; receiving Polymyxin B hemoperfusion in addition to standard ICU care) or the control group (n n = 25; receiving standard ICU care only). The patients were followed up at frequent intervals of 6, 12, 24, 48, and 72 hours. A last follow-up on day 7 was done. The duration of the ICU stay and survival until day 7 were recorded. Changes in clinical and biochemical parameters were also noted and compared. Results: Mean sequential organ failure assessment (SOFA) scores at admission were 3.44 +/- 1.00 and 2.80 +/- 0.82, respectively, in cases and controls. Cases as compared to controls showed faster, and sustainable improvement. No significant difference between the two groups was seen for mortality at day 7. Conclusion: Polymyxin B hemoperfusion tends to show a faster recovery and a non-significant trend towards reduced mortality in ICU-admitted sepsis patients.
引用
收藏
页码:930 / 934
页数:5
相关论文
共 50 条
  • [21] Polymyxin B-Based Hemoperfusion for the Treatment of Endotoxic Shock Preface
    Ronco, Claudio
    Artigas, Antonio
    Antonelli, Massimo
    BLOOD PURIFICATION, 2014, 37 : 1 - 1
  • [22] The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
    De Rosa, Silvia
    Villa, Gianluca
    Ronco, Claudio
    ARTIFICIAL ORGANS, 2020, 44 (02) : 184 - 186
  • [23] The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
    Srisawat, Nattachai
    Tungsanga, Somkanya
    Lumlertgul, Nuttha
    Komaenthammasophon, Chalermchai
    Peerapornratana, Sadudee
    Thamrongsat, Nicha
    Tiranathanagul, Khajohn
    Praditpornsilpa, Kearkiat
    Eiam-Ong, Somchai
    Tungsanga, Kriang
    Kellum, John A.
    CRITICAL CARE, 2018, 22
  • [24] Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
    H Kushi
    H Shoji
    J Nakahara
    T Miki
    K Okamoto
    T Saito
    K Tanjoh
    Critical Care, 10 (Suppl 1):
  • [25] Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study
    Fujimori, Kenji
    Tarasawa, Kunio
    Fushimi, Kiyohide
    ANNALS OF INTENSIVE CARE, 2021, 11 (01)
  • [26] Kinetics of Different Blood Biomarkers during Polymyxin-B Extracorporeal Hemoperfusion in Abdominal Sepsis
    Cotoia, Antonella
    Parisano, Valeria
    Mariotti, Paola Sara
    Lizzi, Vincenzo
    Netti, Giuseppe Stefano
    Ranieri, Elena
    Forfori, Francesco
    Cinnella, Gilda
    BLOOD PURIFICATION, 2024, 53 (07) : 574 - 582
  • [27] Immunomodulatory role of polymyxin B hemoperfusion in gram negative sepsis following stem cell transplant
    Polachirakal, Z. P.
    Sidharthan, N.
    Prabhu, R.
    Rao, R. G.
    Kamath, G.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S88 - S89
  • [28] Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study
    Kenji Fujimori
    Kunio Tarasawa
    Kiyohide Fushimi
    Annals of Intensive Care, 11
  • [29] Polymyxin B-immobilized fiber hemoperfusion therapy improves sepsis-related immunosuppression
    A Kimura
    S Ono
    S Hiraki
    R Takahata
    H Tsujimoto
    M Kinoshita
    S Aosasa
    K Hatsuse
    D Saitoh
    K Hase
    J Yamamoto
    Critical Care, 18 (Suppl 1):
  • [30] STUDY OF THE ROLE OF POLYMYXIN B DIRECT HEMOPERFUSION AS AN ADJUVANT THERAPY IN SEVERE SEPSIS OF VARIED ETIOLOGY
    Javeri, Y.
    Madaan, A.
    Juneja, D.
    Singh, A.
    Nasa, P.
    Singh, O.
    INTENSIVE CARE MEDICINE, 2011, 37 : S41 - S41